SCHEMBL14556078

SCHEMBL14556078

COC(=O)[C@H]1C[C@@H](O)CN1Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ CYP3A4 P08684 3/20 0.47
▸ MAPT P10636 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ KDM2B Q8NHM5 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.44
▸ S1PR1 P21453 3/20 0.44
▸ S1PR5 Q9H228 3/20 0.44
▸ GRK5 P34947 1/20 0.44
▸ CDK8 P49336 1/20 0.44
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ PAX8 Q06710 1/20 0.43
▸ PDGFRA P16234 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ FAAH O00519 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15967644 0.88 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2S1PR1S1PR5GRK5
SCHEMBL14555953 0.88 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2S1PR1S1PR5GRK5
SCHEMBL14486732 0.87 S1PR5 (0.52) ALDH1A1SMN1; SMN2SIGMAR1S1PR1S1PR5
SCHEMBL15967678 0.87 S1PR5 (0.52) ALDH1A1SMN1; SMN2SIGMAR1S1PR1S1PR5
SCHEMBL14486740 0.86 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2SIGMAR1S1PR1S1PR5
SCHEMBL15984303 0.83 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2KDM2BS1PR1S1PR5
SCHEMBL2820776 0.82 MAOA (0.46) CYP3A4MAPTS1PR1S1PR5MAOA
SCHEMBL27852999 0.82 ALDH1A1 (0.75) ALDH1A1SMN1; SMN2KDM2BSIGMAR1KMT2A
SCHEMBL24938939 0.81 CYP3A4 (0.50) ALDH1A1CYP3A4MAPTMAOAMAOB
SCHEMBL4249938 0.81 CYP3A4 (0.50) ALDH1A1CYP3A4MAPTMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013004291-A1 CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR AGONISTS ROTTAPHARM S.P.A. (IT) 2013-01-10 — — WO disclosed
Send feedback